The Event Brought the Austin Community Together for a Night of Fun with a Purpose Featuring Gourmet Food, Cocktails, Casino Games and More
NEWPORT BEACH, Calif., April 6, 2022 – CureDuchenne, a leading global nonprofit focused on finding and funding a cure for Duchenne muscular dystrophy (DMD), and the Revell family hosted the 13th annual Champions to CureDuchenne fundraiser on April 2, 2022. Held at The University of Texas Golf Club, Champions to CureDuchenne brought more than 200 members of the Austin community together to raise $325,000 to help find and fund a cure for Duchenne.
Each year, Tim and Laura Revell rally the community in support of the Champions to CureDuchenne event by bringing together Austin families, friends and neighbors for a night filled with gourmet food, cocktails, casino games, auctions – and one common purpose. All proceeds benefit CureDuchenne as they accelerate scientific research and pioneer educational programs to care for families affected by Duchenne–a progressive, fatal disease affecting 300,000 worldwide.
“We are so grateful to the Revell family for bringing together Austin’s finest for a spectacular evening under the stars with one common purpose,” said CureDuchenne founder and CEO Debra Miller. “With the generous support of the Austin community, we’re able to help improve the lives of everyone affected by Duchenne as we strive for better care and, ultimately, a cure.”
Austin residents Tim and Laura Revell learned their two boys Timothy and Andrew were diagnosed with DMD, the rarest and most deadly form of Muscular Dystrophy, at just two and five years old. DMD is a 100% fatal disease that affects 1 in 5,000 boys. Patients are typically diagnosed as toddlers, lose the ability to walk in their early-teens and often succumb to the disease in their mid-20s. At the time of their boys’ diagnosis, treatments and information on DMD was limited. The Revells began to research the rare disease and connected with CureDuchenne. To date, the family has helped raise more than $4 million through their collective fundraising efforts.
Both of our sons were diagnosed with Duchenne; therefore, we’re doing everything we can to fight for them,” said Tim Revell. “Laura and I are on a mission–our goal is to cure Duchenne, to help those receiving the death sentence that our own family has received, twice. The funds we helped raise at this event pay for next-generation gene therapy research and other clinical trials. We see hope in these trials, which give Laura and I strength to continue to breathe life into our boys.”
For more information, please visit cureduchenne.org.
CureDuchenne is recognized as a global leader in research, patient care, and innovation for improving and extending the lives of those with Duchenne muscular dystrophy. As the leading genetic killer of young boys, Duchenne affects more than 300,000 individuals living today. CureDuchenne is dedicated to finding and funding a cure for Duchenne by breaking the traditional charitable mold through an innovative venture philanthropy model that funds groundbreaking research, early diagnosis, and community education. For more information on how to help raise awareness and funds needed for research, please visit www.cureduchenne.org.